ROSSI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 7.830
AS - Asia 4.886
EU - Europa 4.249
SA - Sud America 725
Continente sconosciuto - Info sul continente non disponibili 252
AF - Africa 176
OC - Oceania 1
Totale 18.119
Nazione #
US - Stati Uniti d'America 7.490
CN - Cina 2.398
SG - Singapore 999
IE - Irlanda 934
IT - Italia 625
BR - Brasile 521
HK - Hong Kong 515
RU - Federazione Russa 507
DE - Germania 449
UA - Ucraina 405
VN - Vietnam 390
FI - Finlandia 371
FR - Francia 281
GB - Regno Unito 250
IN - India 151
CA - Canada 149
SE - Svezia 148
ZA - Sudafrica 101
BD - Bangladesh 80
AR - Argentina 69
JP - Giappone 66
MX - Messico 56
BE - Belgio 47
IQ - Iraq 46
ES - Italia 39
NL - Olanda 33
PL - Polonia 33
CO - Colombia 32
VE - Venezuela 31
ID - Indonesia 27
LT - Lituania 25
PK - Pakistan 24
TR - Turchia 24
EC - Ecuador 23
CR - Costa Rica 22
IL - Israele 20
CZ - Repubblica Ceca 18
AT - Austria 17
TT - Trinidad e Tobago 17
CL - Cile 16
GT - Guatemala 16
NI - Nicaragua 16
UZ - Uzbekistan 15
MY - Malesia 12
JM - Giamaica 11
MA - Marocco 11
PH - Filippine 11
CH - Svizzera 10
KE - Kenya 10
PE - Perù 10
SA - Arabia Saudita 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
GP - Guadalupe 9
PR - Porto Rico 9
PY - Paraguay 9
SV - El Salvador 9
HN - Honduras 8
IR - Iran 8
JO - Giordania 8
KR - Corea 8
AL - Albania 7
AM - Armenia 7
AZ - Azerbaigian 7
UY - Uruguay 7
BG - Bulgaria 6
CW - ???statistics.table.value.countryCode.CW??? 6
DK - Danimarca 6
EE - Estonia 6
EG - Egitto 6
KG - Kirghizistan 6
KZ - Kazakistan 6
PA - Panama 6
PT - Portogallo 6
RO - Romania 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
EU - Europa 5
KH - Cambogia 5
NP - Nepal 5
BO - Bolivia 4
CI - Costa d'Avorio 4
LK - Sri Lanka 4
MU - Mauritius 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
GR - Grecia 3
GY - Guiana 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
SC - Seychelles 3
TH - Thailandia 3
AO - Angola 2
BB - Barbados 2
CU - Cuba 2
ET - Etiopia 2
GA - Gabon 2
HR - Croazia 2
Totale 17.842
Città #
Dublin 929
Chandler 882
Ashburn 764
San Jose 675
Singapore 552
Beijing 549
Dallas 520
Jacksonville 508
Hong Kong 501
Nanjing 461
Council Bluffs 334
Boardman 238
Los Angeles 208
Nanchang 180
Ann Arbor 160
Ho Chi Minh City 150
Lauterbourg 147
New York 147
Princeton 146
Lawrence 140
Helsinki 134
Munich 133
Hebei 129
Pavia 124
Shanghai 123
Wilmington 120
Shenyang 117
Medford 113
Changsha 107
Johannesburg 92
Jiaxing 91
Moscow 90
Santa Clara 83
Hanoi 78
Tianjin 77
Milan 74
Hangzhou 72
São Paulo 69
Buffalo 65
Redondo Beach 63
Tokyo 59
Toronto 56
Pune 54
Orem 48
Rome 43
Brussels 42
Seattle 39
Woodbridge 39
Chennai 37
Piscataway 37
The Dalles 35
Turku 34
Columbus 33
Montreal 33
Chicago 32
Naples 32
London 31
Denver 30
Frankfurt am Main 29
Stockholm 29
Atlanta 28
Warsaw 28
Brooklyn 27
Phoenix 27
Florence 25
Norwalk 24
Houston 23
Da Nang 22
Dearborn 22
Manchester 22
Mexico City 22
Amsterdam 19
Verona 19
Fairfield 18
Newark 17
Poplar 17
Boston 16
Managua 16
Nuremberg 16
San Francisco 16
Washington 16
Tashkent 15
Zhengzhou 15
Charlotte 14
Haiphong 14
North Bergen 14
Baghdad 13
Brasília 13
Curitiba 13
San José 13
Guatemala City 12
Rio de Janeiro 12
Basingstoke 11
Guangzhou 11
Miami 11
Jinan 10
Kingston 10
New Delhi 10
Salvador 10
Biên Hòa 9
Totale 11.587
Nome #
A step forward in understanding the binding of ELAV mimicking peptides to mRNA. An integrated computational and NMR approach 178
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 172
Progettazione e Sintesi di nuovi Ligandi Sigma 165
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 163
Fingerprint Analitico di estratti da Amygdalus Lycioides (Spach.) 162
An eco-friendly enantioselective access to (R)-Naringenin as inhibitor of proinflammatory cytokine release. 161
Formulation of microspheres containing Crataegus monogyna extract in feed design 161
3-Piperidin-4-ylmethyl-3H-benzoxazol-2-one derivatives as sigma ligands 160
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 157
PAN-SIGMA RECEPTOR MODULATORS AS PROMISING ANTICANCER-AGENTS. THE STORY OF RC-106 155
Approaches for multi-gram scale isolation of enantiomers for drug discovery 155
Influence of the Extraction Mode on the Yield of Hyperoside, Vitexin and Vitexin-2”-O-Rhamnoside from Crataegus monogyna Jacq. (Hawthorn) 154
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2) 154
Beyond the affinity for protein kinase C: Exploring 2-phenyl-3-hydroxypropyl pivalate analogues as C1 domain-targeting ligands 154
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 153
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 152
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 151
Anti-inflammatory properties of ethanolic root extract of Eremurus persicus (Jaub and Spach) Boiss, a Kurdish herbal remedy 149
Chiral Flavanones from Amygdalus lycioides Spach: Structural Elucidation and Identification of TNFalpha Inhibitors by Bioactivity-guided Fractionation 147
Design, synthesis and pharmacological activity of new antinociceptive agents 146
Design and synthesis of a (N-alkylaminoalkyl-substituted)arylalkenylamide drug discovery library 145
(R)-(-)-Aloesaponol III 8-methyl ether from eremurus persicus: A novel compound against leishmaniosis 145
Sigma receptor modulators: a patent review. 144
New perspectives in cancer therapy: the biotin-antitumor molecule conjugates 144
Marrubium vulgare l. leave extract: Phytochemical composition, antioxidant and wound healing properties 144
Synthesis of novel sigma ligands. Investigation on the application of Pd(0) EnCatTM 30NP in conventional hydrogenation and CTH MW-assisted protocols 143
Novel sigma ligands: design, preparation and biological evaluation 141
An efficient procedure based on MW-assisted Horner–Wadsworth-Emmons reaction for the synthesis of (Z)-3,3-trisubstituted alpha, beta-unsaturated esters 141
Design, synthesis and biological evaluation of new sigma ligands based on arylalkenylaminic scaffold 139
Synthesis and Pharmacological Evaluation of New N-methyl-arylpyrrolidinols with Analgesic Activity 139
Enantiomeric Resolution and Absolute Configuration of a Chiral δ-Lactam, Useful Intermediate for the Synthesis of Bioactive Compounds 139
Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma 1 ligands. 138
Microwave and Polymer Assisted Synthesis of a Small Library of alpha,beta-Unsaturated Methyl Esters via the Witting Reaction 138
ARE we stable? An integrated in vitro/in silico approach for the study of Embryonic Lethal Abnormal Vision protein and mRNA interactions. 137
Gaining in Pan-Affinity Towards Sigma 1 and Sigma 2 Receptors. SAR studies on arylalkylamines 137
Novel Compounds Targeting the RNA-Binding Protein HuR. Structure-Based Design, Synthesis, and Interaction Studies 137
Direct HPLC enantioseparation of new chiral sigma 1 ligands on coated polisaccharide-based chiral stationary phases. 136
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. 136
Identification of a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. 135
Eremurus persicus Boiss: ethnobotanical relevance, analytical fingerprint and preliminary biological results of root extracts 135
Identification of Peptides with ELAV-like mRNA Stabilizing Effect: An Integrated In Vitro/In Silico Approach 134
Chiral arylpyrrolidinols: preparation and biological profile 133
Drug discovery from plants: antimicrobial evaluation of Amygdalus lycioides (Spach.) branch extracts 133
Insight into GEBR-32a: Chiral resolution, absolute configuration and enantiopreference in PDE4D inhibition 133
Discovery of new and selective sigma 1 ligands potentiating nerve growth factor induced neurite outgrowth in PC12 cells 132
In silico exploration of the Embryonic Lethal Abnormal Visionprotein-mRNA interaction followed by in vitro bioassays for the identification of peptides potentially useful in neurodegenerative diseases treatment 132
Epigenetic effect of naringenin: effects of (S)-naringenin and (R)-naringenin on miR-17-3p and miR-25-5p expression levels. 132
An Analytical and Scale-Up Separation by HPLC and SFC of theFlavonoid Naringenin on a RegisPack® Chiral Stationary Phase 132
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 131
A step forward in the sigma enigma: the role of chirality in the interaction ligand-sigma1 receptor 130
Are sigma receptor modulators a weapon against multiple sclerosis disease? 130
Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016). 129
Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization 129
Antibacterial activity of Amygdalus Lycioides (Spach.): screening of different branch extracts 128
Chemical and biological profile of racemic and optically active dialkylaminoalkylnaphthalenes with analgesic activity. 128
NOVEL PKC ALPHA LIGANDS: RATIONAL DESIGN, PREPARATION AND BIOLOGICAL INVESTIGATION 126
Beyond the affinity for the Protein Kinase C: a critical evaluation of 2-fenil-3hydroxypropyl pivalate analogs targeting the C1 domain 126
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 125
One-pot synthesis of alfa,beta-unsaturated carboxylic acid via tandem Wittig olefination-hydrolysis reaction under combined microwave and ultrasound irradiation. 124
FLAVANONES FROM AMYGDALUS LYCIOIDES SPACH: ISOLATION, CHARACTERIZATION AND BIOLOGICAL EVALUATION 124
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration 123
IDENTIFICATION OF NEW LIGANDS FOR SIGMA RECEPTORS.DESIGN AND SYNTHESIS OF A BETA-AMINOKETONIC DRUG DISCOVERY LIBRARY 123
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 123
Enantioselective modulatory effects of (S)-naringenin and (R)-naringenin on miR-17-3p and miR-25-5p 123
MW-assisted Fischer synthesis of new indolylimidazole and indolyltriazole derivatives 122
Small peptides able to mimic ELAV RNA-binding proteins: preparation and biological evaluation 120
New biotinilated spacers for studying the interaction of ELAV mimicking peptides with the target mRNA 120
Towards sigma1 receptor agonists as neuroprotective agents. Preparation, configurational assignment and in vitro biological profile 120
Microwave-Assisted Extraction and HPLC-UV-CD Determination of (S)-usnic Acid in Cladonia foliacea 120
The use of a microwave-assisted solvent extraction coupled with HPLC-UV/PAD to assess the quality of Marrubium vulgare L. (white horehound) herbal raw material 119
New perspectives in neurodegenerative diseases: chiral resolution and configurational assignment of novel PKC alpha ligands 118
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 118
Preparation of novel analgesics via diastereoselective nucleophilic addition to 1-dimetylamino-2-methylpentan-3-one 117
Chiral 2-phenyl-3-hydroxypropyl esters as PKC-alpha modulators: HPLC enantioseparation, NMR absolute configuration assignment, and molecular docking studies 116
Diffusion-ordered spectroscopy and saturation transfer difference NMR spectroscopy studies of selective interactions between ELAV protein fragments and an mRNA target 115
Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical Spectroscopy 115
The role of chirality in a set of key intermediates of pharmaceutical interest, 3-aryl-substituted-γ-butyrolactones, evidenced by chiral HPLC separation and by chiroptical spectroscopies 114
BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR Application 114
Synthesis and in vitro evaluation of novel pan-SR modulators: Identification of (E)-4-benzyl-1-[3-(naphthalen-2-yl)but-2-en-1-yl]piperidine (RC-106) as potential anticancer agent. 113
High-Throughput Lipophilicity Screening of Opioid-Like Analgesics: Validation of Computational Methods by Means of RP-HPLC Analysis 112
DRUG DISCOVERY FROM PLANTS: TRADITIONAL HERBAL REMEDIES AS SOURCE FOR NEW LEAD COMPOUNDS 112
Novel enantiopure sigma receptor modulators: Quick (semi-)preparative chiral resolution via hplc and absolute configuration assignment 111
Polymer-Assisted Solution-Phase Synthesis under combined Ultrasound and Microwave Irradiation: Preparation of alpha,beta-Unsaturated Esters and Carboxylic Acids, Key Intermediates of Novel Sigma Ligands. 110
In vivo pharmacokinetic study and CNS distribution of the sigma1 receptor agonist (R)-RC-33, a promising neuroprotective agent 110
Synthesis and biological evaluation of small peptides able to mimic ELAV RNA-binding proteins: new perspective in neurodegenerative diseases treatment 109
PEG 400/cerium ammonium nitrate combined with microwave-assisted synthesis for rapid access to beta-amino ketones. an easy-to-use protocol for discovering new hit compounds 109
Discovery of Small Peptides Derived from Embryonic Lethal Abnormal Vision Proteins Structure Showing RNA-Stabilizing Properties 109
Enantioselective Modulatory Effects of Naringenin Enantiomers on the Expression Levels of miR‐17‐3p Involved in Endogenous Antioxidant Defenses 109
Binding Studies and Quantitative Structure-Activity Relationship of 3-Amino-1H-Indazoles as Inhibitors of GSK3beta 108
Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity 108
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain 107
Novel chiral sigma 1 receptor ligand potentiating NGF-induced neurite outgrowth in PC12 cells 107
New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative 107
Structural Insights into the Ligand-LsrK Kinase Binding Mode: A Step Forward in the Discovery of Novel Antimicrobial Agents 106
Polymer-Assisted Solution-Phase Synthesis under Combined Ultrasound and Microwave Irradiation: Preparation of alpha,beta-Unsaturated Esters and Carboxylic Acids, Key Intermediates of Novel Sigma Ligands. 106
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents 106
CHAPTER 12: Sigma Receptors as New Target for Multiple Sclerosis 106
Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach 105
PKC in regenerative therapy: New insights for old targets 104
Preliminary study on TNF alpha-blocker activity of Amygdalus lycioides Spach extracts 103
Totale 13.050
Categoria #
all - tutte 73.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 0 0 0 9 21 13 52 40 30 93 390
2022/20232.456 234 222 26 173 238 249 0 135 1.075 15 60 29
2023/20241.039 117 166 24 48 97 261 65 72 5 40 79 65
2024/20252.656 43 190 73 80 132 185 138 148 663 100 311 593
2025/20265.921 487 326 769 680 845 249 1.048 251 554 433 144 135
2026/20271.703 92 293 355 680 283 0 0 0 0 0 0 0
Totale 18.119